(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory...
Stats | |
---|---|
Šios dienos apimtis | 33.00 |
Vidutinė apimtis | 12 280.00 |
Rinkos kapitalizacija | 307.68M |
EPS | $0.220 ( 2023-11-14 ) |
Kita pelno data | ( $0 ) 2024-06-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 5.35 |
ATR14 | $0 (0.00%) |
Procaps Group S.A. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
PIII | 0.974 |
CREG | 0.965 |
PCSA | 0.96 |
SNPX | 0.959 |
NCBS | 0.959 |
MTP | 0.959 |
LGMK | 0.959 |
NAKD | 0.957 |
PLIN | 0.957 |
UTME | 0.956 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
PROF | -0.973 |
ARTEU | -0.97 |
ACLS | -0.969 |
JMAC | -0.967 |
CFFE | -0.965 |
BRAC | -0.965 |
GENQ | -0.963 |
FMIV | -0.961 |
AHRN | -0.961 |
HERA | -0.96 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Procaps Group S.A. Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $409.92M |
Bruto pelnas: | $239.57M (58.44 %) |
EPS: | $0.420 |
FY | 2022 |
Pajamos: | $409.92M |
Bruto pelnas: | $239.57M (58.44 %) |
EPS: | $0.420 |
Financial Reports:
No articles found.
Procaps Group S.A.
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.